YPB/Codeifai can claim that they achieved their best-ever half year result, but the numbers speak for themselves when they report....
"The group incurred an operating loss after tax for the half-year of $2,005,358,had net cash outflows from operating activities of $910,947and a deficiency of current assets over current liabilities of $2,438,918. As at 30 June 2024, the Group has cash and cash equivalents of $108,502."
1) The operating loss of $2m is up by 147% compared to the loss for the same period in 2023.
2) Revenue was $528k only up 10% on 2023 despite so many announcements of sales successes.
2) Still burning through as much cash as they did in 2023 at over $900k for the 6 months.
3) Started the September quarter with only $109k in cash and cash equivalents. They had to borrow $45k at 25% interest rate before securing share placement with current shareholders and sophisticated investors of $500k at share price of 0.15c. With shares currently trading at 0.1c, those who participated in this share placement have copped a 33 1/3% loss even before the month is out. It doesn't augur well when the share price is at rock bottom 0.1c and they will have to do a further capital raise before the end of the year.
Other than change of name, nothing much else has changed!
- Forums
- ASX - By Stock
- Ann: Codeifai achieves best-ever half year result
CDE
codeifai limited
Add to My Watchlist
4.29%
!
7.3¢

YPB/Codeifai can claim that they achieved their best-ever half...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
7.3¢ |
Change
0.003(4.29%) |
Mkt cap ! $32.33M |
Open | High | Low | Value | Volume |
7.5¢ | 8.5¢ | 5.5¢ | $1.031M | 14.90M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 158000 | 7.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.7¢ | 85000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 158000 | 0.072 |
1 | 250000 | 0.071 |
4 | 443571 | 0.070 |
3 | 260000 | 0.069 |
1 | 400000 | 0.068 |
Price($) | Vol. | No. |
---|---|---|
0.077 | 85000 | 2 |
0.078 | 140000 | 1 |
0.079 | 400000 | 2 |
0.080 | 170275 | 3 |
0.082 | 40000 | 1 |
Last trade - 16.12pm 01/07/2025 (20 minute delay) ? |
Featured News
CDE (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Dr. Steven Gourlay, CEO
Dr. Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online